Item 8.01. Other Events.

On July 7, 2009, Amylin Pharmaceuticals, Inc. issued a press release announcing that its New Drug Application for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. Number Description 99.1 Press release issued by Amylin in July 7, 2009

---